Integrity for Payers

Leverage Real-World Data To Support Claims

Payors and their beneficiaries are increasingly concerned about the rising cost of healthcare. As a result, healthcare providers must provide payors supporting evidence of clinical utility and/or justification of medical necessity. In addition, healthcare providers must submit quality of care documentation including documentation of clinical improvement activities to avoid penalties and maximize reimbursement. Integrity Laboratories’ reporting capabilities include payer-defined quality metric reporting as well as healthcare data warehouse capabilities that allow for the development of real-world evidence (RWE) that can be used in support of clinical utility and medical necessity.

Integrity Laboratories began testing for SARS-CoV-2 (COVID-19) under Emergency Use Authorization (EUA) on March 23.

Please direct all inquiries to for immediate review.

Click Here for CDC recommendations for Identifying Monkeypox.

FDA Authorization Letter   |   FDA EUA Summary

CARES Act Statement